葛兰素史克Glaxosmithkline（GSK）2025年第三季度财报电话会议纪要「LSE」（英文版）（24页）.pdf

1、Investor Relations Q3 2025 results 1 Confidential Conference call and webcast for investors and analystsConference call and webcast for investors and analysts Wednesday,Wednesday,29 October29 October 2025 at 12:00 2025 at 12:00 GMGMT T Introduction|Introduction|Constantin FestConstantin Fest Slide 1

2、Slide 1 Conference call and webcast for investors and analysts Slide Slide 2 2|Agenda|Agenda Ladies and gentlemen,a very warm welcome to the GSK Q3 2025 results call.I am delighted to be joined today by Emma Walmsley,Luke Miels,Deborah Waterhouse and Julie Brown,with Tony Wood and David Redfern join

3、ing for Q&A.Todays call will last approximately one hour with the presentation taking around 30 minutes and the remaining time for your questions.Please ask only 1-2 questions so that everyone has a chance to participate.Before we start,please turn to slide 3.Slide Slide 3 3|Cautionary statement reg

4、arding forward|Cautionary statement regarding forward-looking statementslooking statements This is the usual safe-harbour statement.We will comment on our performance using constant exchange rates or CER unless otherwise stated.I will now hand over to Emma on slide 4.Investor Relations Q3 2025 resul

5、ts 2 Confidential Q3 2025 strong performance improves furtherQ3 2025 strong performance improves further|Emma Walmsley|Emma Walmsley Slide 4Slide 4 Thank you and welcome to everybody joining us today.Please turn to the next slide.Slide Slide 5 5|2025 strong performance improves further2025 strong pe

6、rformance improves further:QQ3 3 HighlightsHighlights Our third quarter results once again demonstrate GSKs continued strong performance with positive momentum driving an upgrade in our guidance for the year.They also further demonstrate the quality and strength of GSKs portfolio,with sales driven b